Psychopharmacology of Schizophrenia in Children and Adolescents
Overview
Authors
Affiliations
The past 5 five years have seen major advances in the diagnosis and treatment of schizophrenia in children and adolescents. This article, reviews the clinical and diagnostic characteristics of schizophrenia in youth with an eye toward recent findings. This article also provides a more extensive review and update of the psychopharmacology of early-onset schizophrenia.
Treatment Analysis of Very Early and Early Onset Psychosis in the Youth Inpatient Setting.
Summerson A, Kalosieh J, Kompella S, Villalba C, Kodali Y HCA Healthc J Med. 2025; 5(6):661-670.
PMID: 39790696 PMC: 11708942. DOI: 10.36518/2689-0216.1637.
Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data.
Szatmari B, Barabassy A, Harsanyi J, Laszlovszky I, Sebe B, Gal M Front Psychiatry. 2020; 11:61.
PMID: 32194443 PMC: 7062963. DOI: 10.3389/fpsyt.2020.00061.
A Review of Childhood-Onset Schizophrenia.
Kendhari J, Shankar R, Young-Walker L Focus (Am Psychiatr Publ). 2020; 14(3):328-332.
PMID: 31975813 PMC: 6526799. DOI: 10.1176/appi.focus.20160007.
Analyzing the influence of BDNF heterozygosity on spatial memory response to 17β-estradiol.
Wu Y, Du X, van den Buuse M, Hill R Transl Psychiatry. 2015; 5:e498.
PMID: 25603414 PMC: 4312832. DOI: 10.1038/tp.2014.143.